Sponsored by:

TAVR Resource Center

Impact of TAVI-Induced LBBB on Mortality
Christopher P. Cannon, MD, FACC
Education

 
News and Updates

  • FDA Expands Indication for Transcatheter Heart Valve (Sept. 2013)
  • TAVR vs. Surgical AVR in Severe Aortic Stenosis (JACC) (April 2013)
  • FDA Approves IDE for ACC and STS to Study Alternative Approaches to TAVR (Feb. 2013)
  • Analysis of TAVR Finds Transfemoral Approach More Cost-Effective Than Surgery (JACC)
    (Dec. 2012)
  • Case Series Shows Potentially Reversible Cause of THV Dysfunction (JACC) (Dec. 2012)
  • FDA Approves Expanded Indications for Transcatheter Heart Valve
  • Transcatheter Valve-in-Valve Procedure Is Effective in Patients With Degenerative Bioprosthetic Surgical Valves (Circulation)
    (Oct. 2012)
  • Case Challenge: Valve-in-Valve TAVI With Postoperative High Gradient (Oct. 2012)
  • Transcatheter Aortic Valves Provide Long-Term Stability; Mortality Remains High (JACC)
    (Oct. 2012)
  • Separate Studies Explore Advances in TAVR: What Are the Implications of This New Therapy? (Aug. 2012)
  • ACC Testifies Before FDA Advisory Panel on Pre-Market Approval of the Transcatheter Heart Valve (June 2012)
  • FDA Approves Heart Valve Trial (June 2012)
  • TAVR in 2012: What Are Options for U.S. Patients With Aortic Stenosis (May 2012)
  • CMS Releases Official National Coverage Determination of TAVR (May 2012)
  • TAVR Outcomes With Mitral Regurgitation (JACC) (April 2012)
  • Cost-Effectiveness of TAVR (Circulation)
    (Feb. 2012)
  • Clinical Documents

  • SCAI/AATS/ACCF/STS Expert Consensus Statement on Operator and Institutional Requirements for TAVR (March 2012)
  • ACCF/AATS/SCAI/STS Expert Consensus Document: TAVR (Jan. 2012)
  • SCAI/AATS/ACCF/STS Specialty Society Statement on Credentialing Criteria for Institutions and Physicians for TAVR (Jan. 2012)
  • Gender Differences in TAVI for Severe Stenosis (JACC) (Jan. 2012)
  • Data Collection

     
    Advertisement
    Advertisement